文献速递心外重症与机械循环支持

2018年成人心脏分配政策变更后一年心脏结局的全国评估

A national assessment of one-year heart outcomes after the 2018 adult heart allocation change.
PubMed 文献 · J Heart Lung Transplant · 2022-08-28

PURPOSE: On 10/18/2018 the Organ Procurement and Transplantation Network (OPTN) implemented modifications to adult heart allocation to better stratify the most medically urgent candidates by WL mortality.…

要点

  • 政策实施后移植中位等待时间由226天降至85天。
  • 整体一年患者生存率政策前91.3% vs 政策后91.8%,无显著差异(p=0.44)。
  • LVAD和IABP亚组一年生存率政策前后均无显著差异。

核心结论

  • 政策改善了最紧急候选者按等待名单死亡风险的分层,缩短了中位等待时间,提高了移植率,且未观察到对一年患者生存率的不良影响。
  • 未观察到对使用IABP、ECMO或LVAD列入或移植的候选者的不良影响。

研究设计与样本

  • 按医疗紧急状态和政策时期进行等待名单死亡竞争风险分析和Kaplan-Meier一年移植后生存分析。
  • 对使用器械的候选者和受者亚组进行类似分析。

主要发现

  • 政策实施前1A状态候选者因死亡或病情过重无法移植而移出等待名单的累积发生率最高,移植累积发生率也最高,其次为1B和2状态。
  • 移植受者的中位移植等待时间从226天降至85天。
  • 整体一年患者生存率政策前为91.3%(90.2,92.4),政策后为91.8%(90.8,92.9),p=0.44,无显著差异。
  • LVAD受者一年生存率政策前为91.7%(90.1,93.2),政策后为91.4%(89.7,93.2),p=0.85,无显著差异。
  • IABP受者一年生存率政策前为91.7%(88.1,95.4),政策后为92.1%(90.1,94.0),p=0.92,无显著差异。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: On 10/18/2018 the Organ Procurement and Transplantation Network (OPTN) implemented modifications to adult heart allocation to better stratify the most medically urgent candidates by WL mortality. This paper reviews two years of post-policy monitoring with focus on post-transplant outcomes, especially for recipients with MCSDs. METHODS: Cohorts of WL additions and recipients pre (10/18/16-10/17/18) and post (10/18/18-10/17/20) policy implementation were compared using the OPTN database. Competing risks analyses of waitlist mortality and Kaplan-Meier one-year post-transplant survival were performed by medical urgency statuses and policy era. Similar analyses were performed for subsets of candidates and recipients on devices. RESULTS: Pre-implementation status 1A candidates had the highest cumulative incidence of removal from the waitlist due to death or too sick to transplant and the highest cumulative incidence of transplant, followed by statuses 1B and 2. Median time to transplant decreased from 226 to 85 days for those transplanted. There was no difference in one-year patient survival (pre=91.3% [90.2, 92.4]; post=91.8% [90.8, 92.9]; p=0.44) overall, or for recipients transplanted with an LVAD (pre=91.7% [90.1, 93.2]; post=91.4% [89.7, 93.2]; p=0.85) or IABP (pre=91.7% [88.1, 95.4]; post=92.1% [90.1, 94.0]; p=0.92). CONCLUSION: The policy improved stratification of the most medically urgent candidates according to risk of death on the WL with decreased median wait times, higher transplant rates and no observed adverse effect on 1-year patient survival. No adverse effects for candidates listed or transplanted on IABP, ECMO, or LVAD were observed.

来源:J Heart Lung Transplant,查看原文。版权归原作者所有。

引用

  1. Bradbrook K, Goff RR, Lindblad K, et al. A national assessment of one-year heart outcomes after the 2018 adult heart allocation change. J Heart Lung Transplant. 2022. PMID: 36184382. doi:10.1016/j.healun.2022.08.018

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。